Evaluating the Transporter Protein Inhibitor Probenecid In Patients With Epilepsy - Related Studies

Evaluating the Transporter Protein Inhibitor Probenecid In Patients With Epilepsy

This study is currently recruiting participants.

Study NCT00610532. Last updated on January 28, 2008. Information provided by Ohio State University

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Epilepsy

2	More general conditions related to this trial
		Brain Diseases
		Central Nervous System Diseases
		Nervous System Diseases

3	Interventions listed in this trial
		phenytoin
		phenytoin and probenecid

4	Additional drug interventions recognized in this trial
		Probenecid

5	More general drug interventions related to this trial
		Anticonvulsants
		Antirheumatic Agents
		Central Nervous System Agents
		Gout Suppressants
		Pharmacologic Actions
		Renal Agents
		Therapeutic Uses
		Uricosuric Agents

6	Sponsors listed in this trial
		Ohio State University